Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Pavel ME, Baudin E, Öberg KE. et al.
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.

Ann Oncol 2017;
28 (07) 1569-1575

Bibliographische Angaben herunterladen

Aufrufen in: